Skip to main content
Log in

Alteration in skeletal muscle mass in women with subclinical hypercortisolism

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Despite the well-known deleterious effects of cortisol on skeletal muscle, whether subtle cortisol excess in subclinical hypercortisolism (SH) affects skeletal muscle mass is unknown. Our objective was to understand the effects of the cortisol level on skeletal muscle mass in patients with SH.

Methods

We compared skeletal muscle mass and fat mass (FM) between 21 patients with SH (12 women and 9 men) and 224 controls (67 women and 157 men) with nonfunctioning adrenal incidentaloma (NFAI). Medical records were reviewed, and we measured body composition parameters using bioelectrical impedance analysis and serum cortisol levels after the overnight 1-mg dexamethasone suppression test (DST).

Results

After adjusting for confounding factors, 1-mg DST levels were inversely correlated with appendicular skeletal muscle mass (ASM) (γ = −0.245, P = 0.040), lower limb ASM (γ = −0.244, P = 0.040), and appendicular skeletal muscle index (ASMI; height-adjusted ASM) (γ = −0.229, P = 0.048) in all women, but not men. ASM and ASMI were significantly lower by 6.2% (P = 0.033) and 5.9% (P = 0.046), respectively, in women with SH compared with those with NFAI, but not men. Conversely, FM and percent fat mass were similar between the two groups. Compared with women with NFAI, among those with SH, lower limb, but not upper limb, ASM was lower by 6.8% (P = 0.020).

Conclusions

This study showed that women with SH had lower skeletal muscle mass, especially of the lower limb, and suggested that subtle cortisol excess also has adverse effects on skeletal muscle metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. L.K. Chen, L.K. Liu, J. Woo, P. Assantachai, T.W. Auyeung, K.S. Bahyah, M.Y. Chou, L.Y. Chen, P.S. Hsu, O. Krairit, J.S. Lee, W.J. Lee, Y. Lee, C.K. Liang, P. Limpawattana, C.S. Lin, L.N. Peng, S. Satake, T. Suzuki, C.W. Won, C.H. Wu, S.N. Wu, T. Zhang, P. Zeng, M. Akishita, H. Arai, Sarcopenia in Asia: consensus report of the Asian Working Group for sarcopenia. J. Am. Med. Dir. Assoc. 15, 95–101 (2014)

    Article  PubMed  Google Scholar 

  2. L.K. Chen, W.J. Lee, L.N. Peng, L.K. Liu, H. Arai, M. Akishita, Asian Working Group for Sarcopenia Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for sarcopenia. J. Am. Med. Dir. Assoc. 17, 767.e1–767.e7 (2016).

    Article  Google Scholar 

  3. Y.S. Kim, Y. Lee, Y.S. Chung, D.J. Lee, N.S. Joo, D. Hong, G. Song, H.J. Kim, Y.J. Choi, K.M. Kim, Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J. Gerontol. A. Biol. Sci. Med. Sci. 67, 1107–1113 (2012)

    Article  PubMed  Google Scholar 

  4. M. Ryu, J. Jo, Y. Lee, Y.S. Chung, K.M. Kim, W.C. Baek, Association of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults: the Fourth Korea National Health and Nutrition Examination Survey. Age. Ageing 42, 734–740 (2013)

    Article  PubMed  Google Scholar 

  5. M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev, A. Tabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1–G34 (2016)

    Article  PubMed  CAS  Google Scholar 

  6. G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173, M61–M71 (2015)

    Article  PubMed  CAS  Google Scholar 

  7. A.A. Khaleeli, R.H. Edwards, K. Gohil, G. McPhail, M.J. Rennie, J. Round, E.J. Ross, Corticosteroid myopathy: a clinical and pathological study. Clin. Endocrinol. 18, 155–166 (1983)

    Article  CAS  Google Scholar 

  8. M.A. Minetto, F. Lanfranco, A. Botter, G. Motta, G. Mengozzi, R. Giordano, A. Picu, E. Ghigo, E. Arvat, Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing’s disease. Eur. J. Endocrinol. 164, 985–993 (2011)

    Article  PubMed  CAS  Google Scholar 

  9. R. Muller, E. Kugelberg, Myopathy in Cushing’s syndrome. J. Neurol. Neurosurg. Psychiatry 22, 314–319 (1959)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. E. Olafsson, H.R. Jones Jr., A.T. Guay, C.B. Thomas, Myopathy of endogenous Cushing’s syndrome: a review of the clinical and electromyographic features in 8 patients. Muscle Nerve. 17, 692–693 (1994)

    Article  PubMed  CAS  Google Scholar 

  11. A.C. Ammini, N. Tandon, N. Gupta, A.S. Bhalla, K. Devasenaspathy, G. Kumar, J.P. Sahoo, S. Chittawar, J. Philip, M.P. Baruah, C.S. Dwarakanath, S. Tripathi, Etiology and clinical profile of patients with Cushing’s syndrome: a single center experience. Indian J. Endocrinol. Metab. 18, 99–105 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  12. M.J. Bolland, I.M. Holdaway, J.E. Berkeley, S. Lim, W.J. Dransfield, J.V. Conaglen, M.S. Croxson, G.D. Gamble, P.J. Hunt, R.J. Toomath, Mortality and morbidity in Cushing’s syndrome in New Zealand. Clin. Endocrinol. 75, 436–442 (2011)

    Article  Google Scholar 

  13. F. Pecori Giraldi, M. Moro, F. Cavagnini, Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of Endocrinology, Gender-related differences in the presentation and course of Cushing’s disease. J. Clin. Endocrinol. Metab. 88, 1554–1558 (2003).

    Article  PubMed  CAS  Google Scholar 

  14. M.A. Minetto, F. Lanfranco, G. Motta, S. Allasia, E. Arvat, G. D’Antona, Steroid myopathy: some unresolved issues. J. Endocrinol. Invest. 34, 370–375 (2011)

    Article  PubMed  CAS  Google Scholar 

  15. F. Ferrau, M. Korbonits, Metabolic comorbidities in Cushing’s syndrome. Eur. J. Endocrinol. 173, M133–M157 (2015)

    Article  PubMed  CAS  Google Scholar 

  16. S.H. Lee, K.H. Song, J. Kim, S. Park, S.H. Ahn, H. Kim, Y.Y. Cho, S. Suh, B.J. Kim, J.H. Kim, J.M. Koh, New diagnostic criteria for subclinical hypercortisolism using postsurgical hypocortisolism: the Co-work of Adrenal Research study. Clin. Endocrinol. 86, 10–18 (2017)

    Article  CAS  Google Scholar 

  17. I. Chiodini, Clinical review: diagnosis and treatment of subclinical hypercortisolism. J. Clin. Endocrinol. Metab. 96, 1223–1236 (2011)

    Article  PubMed  CAS  Google Scholar 

  18. D.A. Delivanis, N.M. Iniguez-Ariza, M.H. Zeb, M.R. Moynagh, N. Takahashi, T.J. McKenzie, M.A. Thomas, C. Gogos, W.F. Young, I. Bancos, V. Kyriazopoulou, Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin. Endocrinol. 88, 209–216 (2018)

    Article  CAS  Google Scholar 

  19. E. Van Cauter, R. Leproult, D.J. Kupfer, Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81, 2468–2473 (1996)

    PubMed  Google Scholar 

  20. V. Messier, R. Rabasa-Lhoret, S. Barbat-Artigas, B. Elisha, A.D. Karelis, M. Aubertin-Leheudre, Menopause and sarcopenia: a potential role for sex hormones. Maturitas 68, 331–336 (2011)

    Article  PubMed  CAS  Google Scholar 

  21. I. Janssen, S.B. Heymsfield, R.N. Baumgartner, R. Ross, Estimation of skeletal muscle mass by bioelectrical impedance analysis. J. Appl. Physiol. (1985) 89, 465–471 (2000).

    Article  CAS  Google Scholar 

  22. M. Tosato, E. Marzetti, M. Cesari, G. Savera, R.R. Miller, R. Bernabei, F. Landi, R. Calvani, Measurement of muscle mass in sarcopenia: from imaging to biochemical markers. Aging Clin. Exp. Res. 29, 19–27 (2017)

    Article  PubMed  Google Scholar 

  23. M. Drey, C.M. Berr, M. Reincke, J. Fazel, J. Seissler, J. Schopohl, M. Bidlingmaier, S. Zopp, N. Reisch, F. Beuschlein, A. Osswald, R. Schmidmaier, Cushing’s syndrome: a model for sarcopenic obesity. Endocrine 57, 481–485 (2017)

    Article  PubMed  CAS  Google Scholar 

  24. G. Woodrow, Y. Devine, M. Cullen, E. Lindley, Application of bioelectrical impedance to clinical assessment of body composition in peritoneal dialysis. Perit. Dial. Int.: J. Int. Soc. Perit. Dial. 27, 496–502 (2007)

    Google Scholar 

  25. L. Barzon, N. Sonino, F. Fallo, G. Palu, M. Boscaro, Prevalence and natural history of adrenal incidentalomas. Eur. J. Endocrinol. 149, 273–285 (2003)

    Article  PubMed  CAS  Google Scholar 

  26. F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Ali, M. Giovagnetti, G. Opocher, A. Angeli, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637–644 (2000)

    PubMed  CAS  Google Scholar 

  27. A.R. Hong, J.H. Kim, K.S. Park, K.Y. Kim, J.H. Lee, S.H. Kong, S.Y. Lee, C.S. Shin, S.W. Kim, S.Y. Kim, Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice. Eur. J. Endocrinol. 177, 475–483 (2017)

    Article  PubMed  Google Scholar 

  28. I. Chiodini, V. Morelli, B. Masserini, A.S. Salcuni, C. Eller-Vainicher, R. Viti, F. Coletti, G. Guglielmi, C. Battista, V. Carnevale, L. Iorio, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J. Clin. Endocrinol. Metab. 94, 3207–3214 (2009)

    Article  PubMed  CAS  Google Scholar 

  29. V. Morelli, F. Donadio, C. Eller-Vainicher, V. Cirello, L. Olgiati, C. Savoca, E. Cairoli, A.S. Salcuni, P. Beck-Peccoz, I. Chiodini, Role of glucocorticoid receptor polymorphism in adrenal incidentalomas. Eur. J. Clin. Invest. 40, 803–811 (2010)

    Article  PubMed  CAS  Google Scholar 

  30. H. Siggelkow, M. Etmanski, S. Bozkurt, P. Grobeta, R. Koepp, J. Brockmoller, M.V. Tzvetkov, Genetic polymorphisms in 11beta-hydroxysteroid dehydrogenase type 1 correlate with the postdexamethasone cortisol levels and bone mineral density in patients evaluated for osteoporosis. J. Clin. Endocrinol. Metab. 99, E293–E302 (2014)

    Article  PubMed  CAS  Google Scholar 

  31. A. Szappanos, A. Patocs, P. Gergics, R. Bertalan, A. Kerti, B. Acs, K. Feldmann, K. Racz, M. Toth, The 83,557insA variant of the gene coding 11beta-hydroxysteroid dehydrogenase type 1 enzyme associates with serum osteocalcin in patients with endogenous Cushing’s syndrome. J. Steroid Biochem. Mol. Biol. 123, 79–84 (2011)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the Asan Institute for Life Sciences, Seoul, Republic of Korea (Project No.2014-1215).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seung Hun Lee.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

These authors are co-first authors: Jae Hyeon Kim and Mi Kyung Kwak.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, J.H., Kwak, M.K., Ahn, S.H. et al. Alteration in skeletal muscle mass in women with subclinical hypercortisolism. Endocrine 61, 134–143 (2018). https://doi.org/10.1007/s12020-018-1598-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-018-1598-0

Keywords

Navigation